Evaluation of the Effects of Ketorolac Dose on Duration of Analgesia in Emergency Department (ED) Renal Colic Patients
Trial statusRecruiting
Trial phasePhase 4
Trial typeInterventional
Biological sexAll
Age18-65
SponsorHackensack Meridian Health
About this trial
This is a prospective interventional study examining the effect of ketorolac at doses of 15mg versus 30 mg for duration of analgesia in emergency department patients with suspected renal colic.
Eligibility criteria
Qualifiers
Adult emergency department patients < 65 years old
One or more of the following common ED chief complaints associated with the suspected diagnosis of renal colic. These chief complaints include but are not limited to: flank pain, back pain, abdominal pain, left and/or right lower quadrant pain, and/or pelvic pain
Pain score of 4 or greater on the 0-10 NRS
Determination of treatment with IV ketorolac
Disqualifiers
Allergy to ketorolac
Pregnant patients
Previously received analgesic medications within 4 hours prior to administration of ketorolac in our ED
Known or stated history of renal insufficiency
Trial design
Treatments tested in this trial
- Ketorolac
Treatment groups
86 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov